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Atrophic age-related macular degeneration (AMD) is associated with the
subretinal accumulation of mononuclear phagocytes (MPs). Their role in
promoting or inhibiting retinal degeneration is unknown. We here show that
atrophic AMD is associated with increased intraocular CCL2 levels and subretinal
CCR2þ inflammatory monocyte infiltration in patients. Using age- and light-
induced subretinal inflammation and photoreceptor degeneration in Cx3cr1
knockout mice, we show that subretinal Cx3cr1 deficient MPs overexpress CCL2
and that both the genetic deletion of CCL2 or CCR2 and the pharmacological
inhibition of CCR2 prevent inflammatory monocyte recruitment, MP accumula-
tion and photoreceptor degeneration in vivo. Our study shows that contrary to
CCR2 and CCL2, CX3CR1 is constitutively expressed in the retina where it
represses the expression of CCL2 and the recruitment of neurotoxic inflammatory
CCR2þ monocytes. CCL2/CCR2 inhibition might represent a powerful tool for
controlling inflammation and neurodegeneration in AMD.
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INTRODUCTION
Age‐related macular degeneration (AMD) is the leading cause
of irreversible blindness in the industrialized world (Klein
et al, 2004). There are two clinical forms of late onset AMD: the
fast‐developing exudative form (wet AMD) deﬁned by choroidal
neovascularization (CNV) and the slow‐developing atrophic
form characterized by a progressing lesion of the retinal pigment
epithelium (RPE) and photoreceptors known as geographic
atrophy (GA) (Klein et al, 2007; van Leeuwen et al, 2003).
Markers of inﬂammation, such as plasma levels of activated
complement factor 3 (C3a) (Machalinska et al, 2009) and C‐
reactive protein (Hong et al, 2011), have been shown to increase
in wet AMD patients. Both forms of AMD are associated with
a polymorphism of Complement factor H (CfH) (Edwards
et al, 2005; Haines et al, 2005; Klein et al, 2005; Maller
et al, 2006).
In GA patients, cells that are positive for microglial cell (MC)/
macrophage (Mf) markers accumulate in the subretinal space
(Gupta et al, 2003; Penfold et al, 1997). MCs and macrophages
(Mf) are part of the mononuclear phagocyte (MP) system that
also includes blood monocytes (Mo), tissue macrophages
and dendritic cells (DCs) (Chow et al, 2011; Ransohoff &
Cardona, 2010; Wynn et al, 2013). Distinct types of MPs, exert
different functions, but are difﬁcult to distinguish immunohis-
tochemically, as they constitutively express or induce similar
markers (Gautier et al, 2012; Ransohoff & Cardona, 2010).
While MCs are recognized to have neuroprotective functions
(Tremblay et al, 2011), the sustained presence of inﬂammatory
Mos (iMos) can be detrimental in neurodegenerative conditions
such as multiple sclerosis and stroke (Conductier et al, 2010;
Ransohoff, 2009). The nature of the MPs that accumulate in the
subretinal space in GA patients is not known, as non‐speciﬁc
markers were used at the time of their observation (Gupta
et al, 2003; Penfold et al, 1997). Their possible role in
photoreceptor rescue or degeneration is unknown.
Molecular markers that differentiate iMos and inﬂammatory
Mfs (iMfs) from MCs include CCR2 and CX3CR1: MCs do not
express CCR2 (Mizutani et al, 2011), but do express high levels
of CX3CR1 (Geissmann et al, 2003; Guo et al, 2012; Saederup
et al, 2010). Furthermore, CCR2 cannot be induced in MCs
(Saederup et al, 2010). CCL2 signalling through CCR2 and
CX3CL1 signalling through CX3CR1 are key factors in Mo
recruitment to a tissue lesion (Combadiere et al, 2003; Comba-
diere et al, 2008). The genetic deletion of Ccl2 and Ccr2 is
associated with reduced MP accumulation in various tissue
lesions, including the central nervous system (Conductier
et al, 2010; Fife et al, 2000; Huang et al, 2001; Izikson
et al, 2000; Ransohoff, 2009). CX3CL1 is an atypical chemokine.
It is expressed as a transmembrane protein that mediates
integrin‐like intracellular adhesion and can be cleaved by
proteases into a soluble form that has chemotactic properties
(Bazan et al, 1997). The genetic deletion of Cx3cr1 is associated
with reduced MP accumulation in peripheral tissues (Comba-
diere et al, 2003), but MP accumulation and neuronal apoptosis
are increased in the central nervous systems of Cx3cr1‐deﬁcient
mice (Cardona et al, 2006; Ransohoff, 2009).
MPs are scarcely present in the photoreceptor cell layer and
subretinal space of young, pigmented, adult wildtype mice but
accumulate with age (Xu et al, 2008). In the eye, CX3CL1 is
constitutively expressed as a transmembrane protein in retinal
neurons (Silverman et al, 2003) and seems to provide a tonic
inhibitory signal to CX3CR1 bearing retinal MCs that keeps
these cells in a quiescent surveillance mode under physiological
conditions (Combadiere et al, 2007; Ransohoff, 2009). Cx3cr1
deﬁciency in mice leads to a strong increase of subretinal
MP accumulation with age and after a light‐challenge; the
accumulation of Cx3cr1‐deﬁcient MPs is also associated with
photoreceptor degeneration (Combadiere et al, 2007; Ma
et al, 2009; Raoul et al, 2008a). Although these features do
not mimic all the aspects of AMD (Drusen formation and RPE
atrophy) they do model subretinal inﬂammation and associated
photoreceptor degeneration, two hallmarks of AMD (Gupta
et al, 2003). Cx3cr1 deletion also increases intraretinal and
subretinal MP accumulation in diabetes (Kezic et al, 2013) and
intraretinal MP accumulation and retinal degeneration in a
paraquat‐induced retinopathy model (Chen et al, 2013).
CCL2 expression in the retina is physiologically low but is
induced in situations of stress such as light‐injury or retinal
detachment (Chen et al, 2012; Nakazawa et al, 2007; Yamada
et al, 2007). There is controversy concerning the long‐term
effects of CCL2/CCR2 deﬁciency on retinal homeostasis. The
spontaneous development of drusen (as in sub‐RPE extracellular
lipid accumulations), neovascularization and degeneration
observed in aged Ccl2/ and Ccr2/ mice (Ambati et al,
2003), has not been reproduced in other laboratories (Chen
et al, 2011; Luhmann et al, 2009). Furthermore, the early onset
AMD‐like phenotype (drusen‐like white spots, photoreceptor
and RPE atrophy before the age of 6 months) described in a
Ccl2/Cx3cr1/ mouse line in numerous publications (Tuo
et al, 2007) has been shown to be due to contamination with the
retinal degeneration 8 (rd8) mutation (Luhmann et al, 2012;
Mattapallil et al, 2012). Recently, rd8 free Ccl2/Cx3cr1/mice
have been shown to display a mild inner retinal phenotype,
but no AMD‐like phenotype (Vessey et al, 2012).
Clinical and experimental data suggest that elevated CCL2
expression (and not its deﬁciency) contributes to wet AMD
pathogenesis. Increased urinary and intraocular CCL2 levels
have been found in patients with wet AMD (Guymer et al, 2011;
Jonas et al, 2010; Newman et al, 2012), CCL2 is induced
in murine CNV (Yamada et al, 2007), and CNV is reduced in
Ccr2/ and Ccl2/ mice (Luhmann et al, 2009; Tsutsumi
et al, 2003). To date, little data is available concerning eventual
CCL2 variations in GA. Ccl2mRNA expression has recently been
shown to increase in all forms of AMD (Newman et al, 2012) and
the CCL2/CCR2 axis is implicated in pathological inﬂammation
and photoreceptor degeneration in chronic photo‐oxidative
stress (Suzuki et al, 2012), in carboxyethylpyrrole‐immuniza-
tion‐induced retinopathy (Cruz‐Guilloty et al, 2013), and in a
model of retinitis pigmentosa (Guo et al, 2012).
We show that the inﬂamed retina in atrophic AMD produces
CCL2 and that potentially neurotoxic CCR2þmonocytes inﬁltrate
the diseased retina. Similarly, CCL2 levels are increased in mice
with subretinal MP accumulation such as aged and photo‐
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injured Cx3cr1/ mice. Using genetic and pharmacological
approaches, we show that CCL2 attracts CCR2þ monocytes to
the eye and participates in subretinal MP accumulation and
photoreceptor degeneration in circumstances such as Cx3cr1
deﬁciency and possibly AMD. CCL2/CCR2 inhibition might
represent a potent therapeutic target for controlling inﬂamma-
tion in atrophic and wet AMD.
RESULTS
Intraocular CCL2 levels and CCR2þ inﬂammatory inﬁltrating
monocytes are increased in atrophic AMD
Intraocular CCL2 levels are increased in patients with wet AMD
(Jonas et al, 2010) and Ccl2mRNA induction is associated with all
forms of AMD (Newman et al, 2012). We measured the CCL2
protein by ELISA in the aqueous humour of 18 patients that
showed characteristic geographic atrophic (GA) lesions upon
funduscopical examination and 22 age‐matched control patients
with no signs of AMD undergoing cataract surgery (see
Supporting Information). CCL2 levels were signiﬁcantly increased
in AMD patients with GA (Fig 1A), while CX3CL1 levels were
around 10 times lower and comparable in both groups (controls:
0.08ng/ml 0.004 SEM; GA: 0.085ng/ml 0.003 SEM). Next,
we performed immunohistochemical analysis to analyse CCL2
expression in macular sections of donor tissues with a history of
AMD and characteristic GA lesions upon postmortem fundoscopy
and age‐matched controls obtained from the Minnesota Lions Eye
bank. Control eyes showed CCL2 staining in vessels (Fig 1B red
staining, arrows), but not in the inner or outer retina. In contrast,
the outer retina adjacent and within the atrophic lesion stained
positive for CCL2 in all lesions analysed (Fig 1C, red staining,
arrows). CCL2 positive ramiﬁed subretinal cells can be regularly
observed in GA sections (Fig 1D, arrows). CCL2 staining was not
observed in RPE cells or in a Müller‐cell‐like distribution. Distant
from the atrophic lesion, CCL2 staining was observed in vessels
only, similar to control sections (data not shown).
CCL2 recruits CCR2þ inﬂammatory monocytes to the
inﬂamed tissue (Geissmann et al, 2010). To detect CCR2þ cells,
we stained central retinal sections (containing multilayered
ganglion cells) from control eyes (Fig 1E) and GA eyes (Fig 1F).
First we tested the CCR2 immunohistochemistry protocol (using
citrate buffer heat antigen retrieval as in parafﬁn section
experiments) on human blood smear preparations. Human
blood smear control CCR2 immunohistochemistry stained about
5% of the leukocyte population in healthy blood donors
(Supporting Information data), corresponding approximately
to the CX3CR1lowCCR2þ inﬂammatory monocyte population
detected by ﬂow cytometry (Geissmann et al, 2003). Further-
more, the CCR2þ cells displayed morphological features of
monocytes (size, nuclear shape) and lymphocytes and neu-
trophils did not stain positive for CCR2 (Supporting Information
data). In parafﬁn sections of control eyes, small round CCR2þ
cells could occasionally be observed intraluminally in major
retinal vessels (Fig 1E inset) but not in the retinal tissue.
Immunohistochemistry omitting the primary antibody did not
reveal any staining (Supporting Information data).
In GA, small lesions of RPE and photoreceptor degeneration
ﬁrst appear para‐foveally and then slowly expand over the
posterior pole, destroying the photoreceptor layer and central
vision (Sarks, 1976). We analysed central sections from GA
donor maculae with visible central lesions. Late stage GA donor
eyes with lesions involving the whole of the posterior pole were
not included in this study. Numerous CCR2þ cells were observed
in the subretinal space adjacent to the Bruch’s membrane
in the atrophic area of GA eyes (Fig 1F, arrows). CCR2þ cells
were regularly observed on the apical side of RPE cells adjacent
to the GA lesion (Fig 1F, inset, arrows; for further examples
see Supporting Information ﬁgures). CCR2þ cells were also
present in laminar deposits (Fig 1G, arrows) and soft drusen
(Fig 1H, arrows; for further examples see Supporting Informa-
tion ﬁgures) in all of the four examined eyes with early AMD.
Double labelling of a GA lesion with leucocyte marker CD18
showed that all subretinal CCR2þ cells (Fig 1I green staining,
arrows) also express CD18 (Fig 1J, arrows, K merge). Human
monocytes and natural killer T cells can both express CCR2 and
CD18 (Mantovani et al, 2004). The cells observed in the sections
displayed morphological features of macrophages (nuclear
shape and cytoplasm/nuclear ratio) rather than natural killer
T lymphocytes, most likely identifying them as CCR2þ MPs
(inﬂammatory macrophages or inﬂammatory DCs). Note that
CD18þCCR2neg (Fig 1J, red arrows) can be observed in the retina
and choroid, where resident macrophages, MCs and DCs are
located (for close views of double labelling see Supporting
Information ﬁgures). Quantiﬁcation of the number of CCR2þ
MPs in the inner retina and the subretinal space in 5 control
maculae from 5 patients and the atrophic lesion of 10GA donor
maculae from 7 patients (expressed as CCR2þ cells/500mm of
the atrophic lesion) show a signiﬁcant reproducible inﬁltration
of CCR2þ MPs in all the atrophic lesions of eyes with GA we
examined (Fig 1L). To quantify the distribution of MPs in GA
lesions more generally, we stained all donor eyes for pan‐MP
marker IBA‐1. IBA‐1þ cells were highly ramiﬁed and located in
the inner retina in sections from control eyes – the photoreceptor
cell layer was exempt of IBA‐1þ MPs (Fig 1M). In GA lesions,
inner retinal IBA‐1þ cells were more rounded and less ramiﬁed
and additional IBA‐1þ MPs were found in the subretinal space
(Fig 1N) as previously described (Combadiere et al, 2007; Gupta
et al, 2003). Quantiﬁcation of the number of IBA‐1þcells in the
inner retina revealed similar numbers in the inner retina for both
groups, but a signiﬁcant increase of subretinal IBA‐1þcells
in the 10GA donor maculae examined (expressed as Ibaþ
cells/500mm of the atrophic lesion; Fig 1O).
Taken together, we show for the ﬁrst time that CCL2 is
increased in eyes with GA and that a signiﬁcant quantity of the
subretinal MPs previously described to accumulate in GA
(Combadiere et al, 2007; Gupta et al, 2003) are CCR2 positive
iMos.
Subretinal Cx3cr1/ MPs over‐express CCL2 in age and
light‐induced inﬂammation
Deletion of Cx3cr1 leads to an age‐dependent increase of
subretinal MPs on a pigmented C57BL/6 (Chinnery et al, 2011;
Combadiere et al, 2007) and BALB/C albino background
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Figure 1. Intraocular CCL2 levels and CCR2þ inﬂammatory monocytes are increased in atrophic AMD.
A. CCL2 ELISA of aqueous humours of geographic atrophy (GA) patients and control subjects (n¼18GA patients n¼22 control patients, student t-test
p<0.0001; Mann–Whitney test p<0.0001).
B–D. CCL2 immunohistochemistry (red staining) on macular sections of (B) control donor tissues, (C and D) within the GA lesion.
E–H. CCR2 immunohistochemistry (red staining) on macular sections of (E) control donor tissues, inset: major retinal vessel containing erythrocytes and
leucocytes, (F) within the GA lesion, inset: adjacent to GA lesion (G) laminar deposit (H) soft drusen.
I–L. (I) CCR2 (green staining), (J) CD18 (red staining), (K) merge double labelling of a GA lesion. (L) Quantification of intraretinal and subretinal CCR2/CD18
positive cells expressed as CCR2þ cells/500mm of the atrophic lesion (n¼10 GA donor maculae from 7 patients: age, mean (SD): 84 (8.8) and n¼5 control
maculae from 5 patients: age, mean (SD): 83 (8.8), students t-test p¼0.001).
M, N. IBA-1 immunohistochemistry (red staining) on macular sections of (M) control donor tissues, (N) within the GA lesion.
O. (O) Quantification of intraretinal and subretinal IBA-1 positive cells expressed as IBA-1þ cells/500mm of the atrophic lesion (subjects same as above,
students t-test p¼0.005). B–L and N and O: representative images from 5 healthy donors, 7 donors (10 eyes) with GA and 3 donors with age related
maculopathy (4 eyes), controls omitting the primary antibody showed no staining. All values are represented as mean SEM. CTL: control; GA: geographic
atrophy; ONL: outer nuclear layer; INL: inner nuclear layer; Ch: choroid; iR: inner retina; sR: subretinal; Scale bar B–J¼50mm.
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(Chinnery et al, 2011; Combadiere et al, 2007); in Cx3cr1/
knockout (Combadiere et al, 2007) and Cx3cr1GFP/GFP knockin
mice (Chinnery et al, 2011; Combadiere et al, 2007). However,
Cx3cr1 deletion in mice does not mimic all aspects of AMD.
Indeed, we did not observe drusen formation and RPE atrophy,
but these mice do model subretinal inﬂammation and associated
photoreceptor degeneration, two hallmarks of AMD (Gupta
et al, 2003).
We ﬁrst analysed whether the MP accumulation in Cx3cr1/
mice is associated with elevated CCL2 expression. Ccl2
mRNA expression shows signiﬁcantly increased expression in
18‐month‐old Cx3cr1/ mice with subretinal MP accumulation
compared to age‐matched wildtype mice (Fig 2A). This
difference is not observed in 2‐ to 3‐month‐old Cx3cr1þ/þ and
Cx3cr1/ mice that do not accumulate subretinal MPs.
Similarly, in light‐challenged 2‐month‐old Cx3cr1/ that
accumulate subretinal MPs (see below), Ccl2 mRNA are
increased at 4 and 14 days (Fig 2B) and CCL2 protein expression
is increased at 14 days (Fig 2C) when compared to light‐
challenged wildtype mice (with little subretinal inﬂammation)
or non‐illuminated Cx3cr1/ mice. It should be noted that
the intensity of the light‐challenge model used herein was
developed to induce subretinal inﬂammation and subsequent
photoreceptor degeneration in the Cx3cr1/ mice but not
in Cx3cr1þ/þ mice (see below). The light intensity is not
strong enough to directly induce photoreceptor apoptosis in
pigmented wildtype animals, contrary to classically used light‐
injury models.
To identify the main CCL2 expressing cells, we performed
immunohistochemical analysis of CCL2 (red staining Fig 2D–G)
on retinal ﬂatmounts at 14 days in light‐challenged Cx3cr1/
mice. Robust CCL2 staining in Cx3cr1/ mice was observed in
IBA‐1 positive MPs (Fig 2D CCL2 red staining, 2E IBA‐1 green
double staining) of the subretinal space. IBA‐1þMCs of the inner
retina (Fig 1G IBA‐1 green staining) did not stain positive for
CCL2 (Fig 2F CCL2 red). Similar staining was observed in aged
Cx3cr1/ mice but never in light‐challenged or aged in
Cx3cr1GFP/GFPCcl2/ control mice.
To study whether subretinal MPs induce or participate in Ccl2
mRNA production in retinal inﬂammation we also compared
Ccl2 mRNA expression 4 days after light‐challenge in the eyes
of MP accumulating Cx3cr1GFP/GFP mice and the eyes of
Cx3cr1GFP/GFPCcr2RFP/RFP mice in which the accumulation is
inhibited (see below). The signiﬁcant Ccl2 mRNA induction
observed in Cx3cr1GFP/GFPmice (as in Cx3cr1/mice Fig 2B) was
completely prevented in Cx3cr1GFP/GFPCcr2RFP/RFP mice and
comparable to wild type and Ccr2/ mice (Fig 2H). Finally,
we analysed Ccl2mRNA on whole‐eye‐lysats and MPs sorted by
ﬂuorescent activated cell sorted (FACS) of PBS perfused
Cx3cr1GFP/GFP mice after 4 days of light challenge. iMos express
high levels of CCR2 and Ly6C and low levels of CX3CR1,
while MCs and resident macrophages express low levels of CCR2
and Ly6C and high levels of CX3CR1 (Ransohoff & Cardona,
2010; Wynn et al, 2013). Ccl2 mRNA was greatly enriched in
sorted GFPlowLy6Chigh cells (pooled from 8 eyes) when
compared to whole‐eye‐lysats, conﬁrming that Cx3cr1‐deﬁcient
Ly6ChighCCR2þMPs strongly express CCL2 in the model (Fig 2I).
The expression in sorted GFPhighLy6Cneg corresponding to
resident Mfs and MCs was found to be much lower.
We have previously shown that subretinal MPs engulf
photoreceptor outer segments (POSs) (Combadiere et al,
2007) known to be rich in phosphatidylserine (Miljanich
et al, 1981). Phagocytosis of substrates rich in phosphatidylser-
ine, such as apoptotic bodies and POS, has been shown to only
induce small amounts of pro‐inﬂammatory mediators and to
promote the resolution of inﬂammation in wild type macro-
phages (Huynh et al, 2002). To evaluate whether CX3CR1
inﬂuences the level of CCL2 expression in Mfs in the subretinal
microenvironment, Cx3cr1þ/þ and Cx3cr1/ macrophages
derived from puriﬁed bone marrow monocytes (bMo) were
incubated with POS prepared from porcine retina. We show
that Ccl2 mRNA expression (Fig 2J) is comparable in control
Cx3cr1þ/þ and Cx3cr1/ Mfs at 18 h of culture. Interestingly,
when the Mfs were derived in the presence of POS, Ccl2mRNA
induction in Cx3cr1/Mfs was signiﬁcantly stronger compared
to Cx3cr1þ/þ Mfs (Fig 2J) suggesting that CX3CR1 signalling
helps to repress CCL2 secretion in subretinal wild type Mfs.
Taken together, several lines of evidence suggest that
subretinal Cx3cr1/ MPs are the main source of CCL2
release in subretinal inﬂammation observed in Cx3cr1/ mice.
We show that the absence of CX3CR1/CX3CL1 signalling in the
subretinal environment fails to repress CCL2 induction in
inﬁltrating Mos. As a result, CCL2 is overexpressed in subretinal
inﬂammation in Cx3cr1/ mice.
CCL2 deletion protects Cx3cr1/ mice from age and
light‐induced subretinal MP accumulation
We have previously shown that Cx3cr1/ mice spontaneously
accumulate subretinal MPs with age and light exposure
(Combadiere et al, 2007; Raoul et al, 2008b). To analyse
the inﬂuence of CCL2 on subretinal MP accumulation
we generated Cx3cr1/Ccl2/ mice, Cx3cr1GFP/GFPCcl2/
mice, and Cx3cr1GFP/GFPCcr2RFP/RFP knockin mice. First, we
evaluated the number of subretinal MPs on 12 month‐old IBA‐1
stained RPE‐ﬂatmounts of C57BL/6 (Fig 3A), Ccl2/ (Fig 3B),
Cx3cr1/ (Fig 3C), and Cx3cr1/Ccl2/ (Fig 3D). Cx3cr1/
mice accumulate numerous subretinal MPs at this age (Fig 3C)
compared to C57BL/6 mice (Fig 3A) kept in the same conditions,
as previously described (Combadiere et al, 2007). In 12‐month‐
old Ccl2/ mice (Fig 3B, 18 month‐old in Supporting
Information data) a slight increase of subretinal MPs compared
to C57BL/6 mice can be observed as previously reported in
much older Ccl2/ mice (20 months and older) (Luhmann
et al, 2009). Importantly, the population of subretinal MP in
Cx3cr1/Ccl2/ mice was strongly reduced compared to
Cx3cr1/ mice of the same age (Fig 3D). Quantiﬁcation of
subretinal MPs at 3, 9 and 12 months shows a strong increase in
numbers in Cx3cr1/ mice at 12 months that is signiﬁcantly
reduced in Cx3cr1/Ccl2/mice at 9 and 12months (Fig 3E). In
light‐challenged Cx3cr1/ mice, subretinal MPs strongly in-
creased compared to controls, peaking at day four and the
accumulationwas signiﬁcantly reduced in Cx3cr1/Ccl2/mice
at 4 and 14 days (Fig 3F). Similarly, light‐challenged Cx3cr1GFP/GFP
mice signiﬁcantly accumulated subretinal MPs compared to
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Figure 2. CCL2 expression in age and light‐challenged Cx3cr1/ mice.
A. Quantitative RT-PCR of Ccl2mRNA normalized with b-actinmRNA of 2- and 18-month-old C57BL/6 and Cx3cr1/mouse retina (n¼4 per group, two-way
Anova, Bonferroni p<0.001).
B. Quantitative RT-PCR of Ccl2 mRNA normalized with b-actin mRNA of non-injured (NI) and at day 4 and day 14 of the light-challenge model of 2- to
3-month-old C57BL/6 and Cx3cr1/ mice (n¼5–6 per group, two-way Anova, Bonferroni p<0,05).
C. CCL2 ELISA protein quantification of retinal protein extracts from non-injured (NI) and at day 14 (d14) of the light-challenge model of 2- to 3-month-old
C57BL/6 and Cx3cr1/ mice (expressed as pg/mg total retinal protein; n¼4 per group, two-way Anova, Bonferroni p<0.001).
D–G. Immunohistochemistry CCL2 (red; arrows), and IBA-1 (green; arrows colocalization yellow) of the subretinal side (D and E) and vitreal aspect (F and G) of a
retinal flatmount from a Cx3cr1/ mouse at day 14 (d14) of the light-challenge model (representative of 3 independent experiments, immunostaining
omitting the primary antibody or performed on Ccl2/ mice served as negative controls).
H. Quantitative RT-PCR of Ccl2mRNA normalized with b-actinmRNA of 2- to 3-month-old C57BL/6, Ccl2/, Ccr2/, Cx3cr1GFP/GFP and Cx3cr1GFP/GFPCcr2RFP/RFP
mice at day 4 of the light-challenge model (d4) (n¼5–6 per group, two-way Anova, Bonferroni p<0.01).
I. Quantitative RT-PCR of Ccl2mRNA normalized with S26 of whole-eye-lysats (set as 1) and FACS-sorted GFPhighLy6Cneg and GFPlowLy6Chigh cells pooled from
8 eyes of PBS perfused Cx3cr1GFP/GFP mice after 4 days of light challenge.
J. (J) Quantitative RT-PCR of Ccl2 mRNA normalized with S26 mRNA of Cx3cr1þ/þ and Cx3cr1/ monocyte derived Mfs cultivated for 18 h with or
without photoreceptor outer segments (POSs, n¼4 per group, two-way Anova Bonferroni p<0.001). All values are represented as mean SEM. Scale bar
D–G¼50mm; CTL: control; þPOS: þphotoreceptor outer segments.
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Figure 3. CCL2 mediates subretinal MP accumulation in age and light‐challenged Cx3cr1/ mice.
A–D. 12 month-old IBA-1 stained RPE-flatmounts of C57BL/6 (A), Ccl2/ (B), Cx3cr1/ (C) and Cx3cr1/Ccl2/ (D).
E. Quantification of subretinal MPs/mm2 at 3, 9 and 12 months (n¼6 per group, two-way Anova Bonferroni p<0,001).
F. Quantification of subretinal MPs/mm2 non-injured and at day 4 and 14 of the light-challenge model of 2- to 3-month-old C57BL/6J, Ccl2/, Cx3cr1/ and
Cx3cr1/Ccl2/ mice (n¼6–9 per group, two-way Anova Bonferroni p<0.001).
G. Quantification of IBA-1 positive subretinal MPs/mm2 in non-injured and at day 14 of the light-challenge model of 2- to 3-month-old C57BL/6J, Ccl2/,
CCR2/, Cx3cr1GFP/GFP, Cx3cr1GFP/GFPCcl2/ and Cx3cr1GFP/GFPCcr2RFP/RFP mice (n¼6–9 per group, two-way Anova Bonferroni p<0.001).
H–K. Representative fundoscopic photographs of 12-month-old C57BL/6 (H), Ccl2/ (I), Cx3cr1/ (J) and Cx3cr1/Ccl2/ (K) (n>8 per group). All values are
represented as mean SEM. Scale A–D¼100mm.
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control mice; the accumulation was signiﬁcantly inhibited
in Cx3cr1GFP/GFPCcl2/ mice, and Cx3cr1GFP/GFPCcr2RFP/RFP
knockin mice at day 14 (Fig 3G). In summary, subretinal MP
accumulation observed in Cx3cr1 deﬁcient mice was signiﬁcantly
inhibited in three distinct, independently bred, double knockout
strains (Cx3cr1/Ccl2/ mice, Cx3cr1GFP/GFPCcl2/ mice and
Cx3cr1GFP/GFPCcr2RFP/RFP knockin mice).
We have previously shown that some of the subretinal MPs
in aged Cx3cr1/ mice engulf lipid‐rich POSs, accumulate
lipid intracellularly and become visible as pseudodrusen in
funduscopy (Combadiere et al, 2007). Eye examination of
12‐month‐old C57BL/6 (Fig 3H), Ccl2/ (Fig 3I), Cx3cr1/
(Fig 3J), and Cx3cr1/Ccl2/ (Fig 3K) revealed these
characteristic yellow‐white deposits in Cx3cr1/ mice (Fig 3J)
but not in the othermouse strains including theCx3cr1/Ccl2/
mice, conﬁrming that CCL2 deletion prevents the appearance of
subretinal MP‐associated pseudodrusen in Cx3cr1/mice. None
of the three generated double knockout mouse strains contained
the rd8 mutation or presented signs of the early onset AMD‐like
features previously described (Tuo et al, 2007).
In summary, using three independently bred double knockout
strains, we show that deletion of CCL2/CCR2 signalling strongly
inhibits subretinal MP accumulation in Cx3cr1 deﬁciency.
Consequently, the number of the fundoscopically visible
pseudodrusen that constitute lipid bloated subretinal MPs are
equally reduced.
CCL2 deﬁciency protects Cx3cr1/ mice from age‐ and
light‐induced photoreceptor degeneration
Subretinal accumulation of Cx3cr1 deﬁcient MPs is associated
with retinal degeneration (Chen et al, 2013; Chinnery et al, 2011)
and more precisely photoreceptor degeneration (Combadiere
et al, 2007). Similarly, in the brain Cx3cr1 deﬁcient MPs display
increased neurotoxicity compared to CX3CR1 expressing MPs
(Cardona et al, 2006). To evaluate the inﬂuence of Ccl2
deﬁciency on photoreceptor degeneration in Cx3cr1/ mice,
we evaluated the photoreceptor cell layer on histological
sections of 12 month‐old mice. Micrographs, taken at equal
distance from the optic nerve show the regular structure of the
outer nuclear layer (ONL, that contains the photoreceptor
nuclei) clearly delimited by the outer plexiform layer in C57BL/6
(Fig 4A), Ccl2/ (Fig 4B), and Cx3cr1/Ccl2/ mice (Fig 4D).
In contrast, Cx3cr1/ mice (Fig 4C) at equal distance from the
optic nerve, display a thinned ONL, an irregular border on
the outer plexiform layer and displaced photoreceptor nuclei in
the inner segments of the photoreceptor (arrow) characteristic
for the macrophage‐associated photoreceptor cell death de-
scribed in retinal detachment (Hisatomi et al, 2003). Photo-
receptor cell nuclei were quantiﬁed in the mouse strains by
counting photoreceptor nucleus rows at increasing distances
from the optic nerve (0mm) and calculated as the area under the
curve. While 12‐month‐old Cx3cr1/ mice displayed a signiﬁ-
cant loss of photoreceptors compared to age matched C57BL/6
mice (not observed at 3 months of age, Supporting Information
data), 12‐month‐old Cx3cr1/Ccl2/ mice were completely
protected against Cx3cr1 deﬁciency dependent degeneration
(Fig 4E).
As shown above, light‐challenge triggers MP accumulation
in 3‐month‐old Cx3cr1/ mice similar to the spontaneous
accumulation observed with age (Fig 3). To evaluate whether
acute MP accumulation induces photoreceptor cell death, we
performed TUNEL‐staining on light‐challenged retina. Displaced
TUNEL positive nuclei (Fig 4F red staining) that also stain
positive for rhodopsin (Fig 4F inset, green staining) can be
observed in the photoreceptor segments of light‐challenged
Cx3cr1/ mice at day 14 in sections (Fig 4F) and ﬂatmounts
(Fig 4G). Similarly, it has been shown that these displaced
photoreceptor nuclei represent dying TUNEL positive photo-
receptors in retinal detachment, where subretinal macrophage
accumulation and photoreceptor degeneration occurs (Hisatomi
et al, 2003). To quantify photoreceptor apoptosis in light‐
challenged mice we prepared TUNEL stained retinal ﬂatmounts
of C57BL/6 (Fig 4H), Ccl2/ (Fig 4I), Cx3cr1/ (Fig 4J), and
Cx3cr1/Ccl2/ (Fig 4K) mice. Flatmounts from Cx3cr1/
mice displayed TUNEL positive cells to a much greater extent
than C57BL/6, Ccl2/ and Cx3cr1/Ccl2/ mice. Quantiﬁca-
tion of TUNEL positive cells per retina shows a signiﬁcant CCL2
dependent increase in Cx3cr1/ mice, as Cx3cr1/Ccl2/
mice were not different from C57BL/6 and Ccl2/mice (Fig 4L).
Taken together, the photoreceptor degeneration observed in
aged and light‐challenged Cx3cr1/ mice is greatly inhibited
in Cx3cr1/Ccl2/ mice that are signiﬁcantly protected from
subretinal inﬂammation.
Subretinal MP accumulation in Cx3cr1/ mice is dependent
on CCL2 mediated monocyte recruitment
Blood monocytes can be divided into two subsets (Geissmann
et al, 2010; Swirski et al, 2007; Tsou et al, 2007): the
CX3CR1lowCCR2þ monocytes, the blood‐borne precursors of
inﬂammatory macrophages and inﬂammatory DCs, and the
CX3CR1highCCR2 monocytes that patrol the vasculature
(Geissmann et al, 2003; Tsou et al, 2007). Inﬁltrating CCR2þ
monocytes downregulate Ccr2mRNA (Wong et al, 1997) and can
give rise to classically‐ and alternatively‐activated macrophages
(Arnold et al, 2007). Brain MCs and tissue resident Mfs do not
express CCR2, but do show high levels of CX3CR1 (Gautier
et al, 2012; Geissmann et al, 2003; Saederup et al, 2010).
To evaluate Cx3cr1 and Ccr2 expression in the retina andMPs,
we compared mRNA expression on whole tissue and isolated
cells by RT‐PCR. Cx3cr1 mRNA was expressed by circulating
monocytes, its expression was stronger in the retina and greatly
concentrated in puriﬁed retinal MCs (Fig 5A). In contrast,
Ccr2 mRNA was expressed in circulating monocytes, but not
detectable in retinal extracts and barely detectable in puriﬁed
retinal MCs (Fig 5B) in control adult wildtype mice. Accordingly,
retinal ﬂatmounts from non‐injured Cx3cr1GFP/þCcr2RFP/þ mice,
expressing the red ﬂuorescent protein under the Ccr2 promoter
and the green ﬂuorescent protein under the Cx3cr1 promoter
(Saederup et al, 2010), conﬁrmed that CCR2 expressing RFPþ
cells (Fig 5C arrow) are very rare in the healthy retina and
morphologically similar to monocytes (small and round). As
suggested by the RT‐PCR, resting retinal MCs did not express
Ccr2 promoter controlled RFP but expressed high levels of
Cx3cr1 promoter controlled GFP as previously described
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(Fig 5D) (Combadiere et al, 2007). The RPE, or any other retinal
cell, did not express RFP or GFP and the photoreceptor cell layer
and subretinal space was devoid of any signiﬁcant amount of
RFPþ or GFPþ cells. We next compared the level of Ccr2 mRNA
expression in Cx3cr1þ/þ and Cx3cr1/ freshly prepared
monocytes and after in vitro differentiation into macrophages
in the presence of POSs to simulate macrophage differentiation
in the subretinal space (Fig 5E). Ccr2 mRNA did not differ
between genotypes, but decreased with macrophage differenti-
ation as previously described (Wong et al, 1997). Our results
suggest that Ccr2 promoter controlled RFP expression, combined
with the dendritic morphological feature, allows for the
identiﬁcation of inﬁltrating Mo‐derived MPs as compared to
migrating MCs for some time after inﬁltration as described in
the brain (Mizutani et al, 2011).
To evaluate whether CCR2þ monocytes are recruited to the
subretinal space in Cx3cr1 deﬁciency, we evaluated RFPþ cells
4 days into a light‐challenge. Ramiﬁed subretinal RFPþ cells
(Fig 5F) that were also positive for GFP (Fig 5G) were
signiﬁcantly more numerous in Cx3cr1GFP/GFPCcr2þ/RFP mice
compared to heterozygote control mice (Fig 5H). More
importantly, signiﬁcantly diminished subretinal RFPþ cells in
Cx3cr1GFP/GFPCcr2RFP/RFP mice conﬁrm that recruitment is greatly
dependent on the CCL2/CCR2 axis (Fig 5H). Our data suggests
that RFPþ monocytes, recruited from the bloodstream, differen-
tiate into ramiﬁed iMf in light‐challenged Cx3cr1 deleted mice.
However, as inﬁltrating Mos quickly downregulate CCR2,
subretinal RFPþ cells in Cx3cr1GFP/GFPCcr2þ/RFP mice probably
only represent a fraction of the monocyte‐derived MPs in the
subretinal space.
Figure 4. CCL2 deﬁciency protects Cx3cr1/ mice from age and light‐induced photoreceptor degeneration.
A–D. Micrographs, taken 1000mm from the optic nerve of 12-month-old C57BL/6J (A), Ccl2/ (B), Cx3cr1/ (C, arrows: photoreceptor nuclei; star: nucleus of
a subretinal macrophage) and Cx3cr1/Ccl2/ (D).
E–G. (E) Photoreceptor nucleus rows at increasing distances (3000mm: inferior pole, þ3000mm: superior pole) from the optic nerve (0mm) in 12-month-old
C57BL/6J, Ccl2/, Cx3cr1/ and Cx3cr1/Ccl2/mice (n¼4–7, the area under the curve in Cx3cr1/mice tested significantly different from the other
strains one-way Anova Bonferroni p<0.05). Hoechst (blue staining), TUNEL (red staining), rhodopsin (green staining) labelling of Cx3cr1/mice at d14 of
the light-challenge model in sections (F inset showing rhodopsin double labelling) and confocal microscopy of flatmounts with z-stack projections (G).
H–K. TUNEL stained retinal flatmounts of d14 light-challenged C57BL/6 (H), Ccl2/ (I), Cx3cr1/ (J) and Cx3cr1/Ccl2/(K) mice.
L. Quantification of TUNEL positive cells per retina (n¼4–6 per group, one-way Anova Bonferroni p<0.01). All values are represented as mean SEM.
ONL: outer nuclear layer. Scale bars: A–D and G¼50mm; F and H–K¼100mm.
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Figure 5. Subretinal MP accumulation and photoreceptor degeneration in Cx3cr1/ mice is dependent on CCL2 mediated monocyte recruitment.
A, B. RT-PCR of relative (A) Cx3cr1 and (B) Ccr2mRNA expression normalized with S26mRNA in C57BL/6 blood monocytes (Mo), retina (R) and retinal microglial
cells (MC) (n¼3 independent cell preparations, all groups significantly different from each other for Cx3cr1 by one-way Anova Bonferoni p<0.05;
Mo significantly different from MC and R for Ccr2 by two-way Anova Bonferoni p<0.001).
C, D. Confocal microscopy of (C) RFP fluorescence and (D) merged RFP and GFP fluorescence of the outer plexiform layer of non-injured Cx3cr1þ/GFPCcr2þ/RFPmice.
E. Quantitative RT-PCR of Ccr2 mRNA normalized with S26 mRNA of Cx3cr1þ/þ and Cx3cr1/ freshly prepared monocytes and monocyte derived Mfs
cultivated for 18 h in direct contact with photoreceptor outer segments (POS) (n¼4 per group, two-way Anova Bonferroni p<0.001 significant difference
in monocytes compared to Mfs; no difference between genotypes).
F, G. (F) RFP fluorescence and (G) merged RFP and GFP fluorescence of Hoechst stained chroidal/RPE flatmount after 4 days of light-challenge of
Cx3cr1GFP/GFPCcr2þ/RFP mice.
H. Quantification of RFP positive subretinal cells after 4 days of light-challenge in Cx3cr1þ/GFPCcr2þ/RFP, Cx3cr1GFP/GFPCcr2þ/RFP and Cx3cr1GFP/GFPCcr2RFP/RFP
mice (n¼4 per group, one-way Anova Bonferroni p<0.01).
I. Quantification of the percentage of CD115þ (inset green staining) and CD115þEdUþ cells (inset red/green staining) of all Hoechst positive leukocytes of
blood smears from day 4 light-challenged Cx3cr1/mice that all received three daily intraperitoneal EdU injections and one daily intravenous injection of
either control or clodronate liposome (n¼4 per group, two-way Anova Bonferroni p<0.001 significant difference in the number of CD115þ and
CD115þEdUþ cells in clodronate liposome treated animals compared to controls).
J, K. IBA-1 (green) EdU (red) double labelled chroidal/RPE flatmount of intraperitoneally EdU-injected light-challenged Cx3cr1/ mice receiving control
liposome injections (J) or clodronate liposome injections (K).
L. Quantification of subretinal IBA-1þ and IBA-1þEdUþ cells of control liposome and clodronate liposomes treated 4 days light-challenged Cx3cr1/ mice
(n¼4mice per group, two-way Anova Bonferroni p<0.001 significant difference in the numbers of subretinal IBA-1þMPs and yIBA-1þEdUþMPs between
clodronate liposome and control liposome treated mice).
M, N. TUNEL stained retinal-flatmounts of control liposome (M) and clodronate liposome (N) treated light-challenged Cx3cr1/ at d14.
O, P. O) Quantification of IBA-1 positive subretinal MPs/mm2 (n¼4–7 per group, Mann–Whitney p¼0.03) and (P) TUNEL positive photoreceptor nuclei in
control liposome and clodronate liposome treated light-challenged Cx3cr1/ at d14 (n¼4–7  Mann–Whitney p<0.0001). All values are represented as
mean SEM. R: Retina; MC: microglial cells; Mo: monocytes; POS: photoreceptor outer segments; lipo: empty control liposomes; lipo-clo: clodronate
liposomes. Scale bars¼50mm.
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To evaluate the participation of monocyte recruitment from
the bloodstream versus resident Mfs and MCs in subretinal MP
accumulation we injected light‐challenged Cx3cr1/mice from
day one to day four with the traceable nucleotide EdU to
permanently mark the quickly dividing monocytes and with
daily intravenous injections of either empty control liposomes
or clodronate containing liposomes that eliminate circulating
monocytes within 24 h (Sunderkotter et al, 2004). We deter-
mined in preliminary experiments that three days of three
intraperitoneal EdU injections/day marks the majority of
circulating monocytes and that subretinal MP recruitment in
light‐challenged Cx3cr1/mice mainly appears at day three and
four. Analysis of EdU CD115 double stained blood smears at day
four revealed that three daily EdU injections rendered 76% of
circulating CD115þmonocytes EdU positive in control liposome
injected mice (Fig 5I). Clodronate liposomes signiﬁcantly
lowered circulating monocytes by 84% (Fig 5I). In the eye,
IBA‐1 (green) and EdU (red) double labelled retinal and
RPE‐ﬂatmounts of light‐challenged control‐liposome‐treated
Cx3cr1/ mice (Fig 5J) revealed numerous IBA‐1þEdUþ MPs
among the IBA‐1þ subretinal MPs. In contrast, subretinal IBA‐1þ
cells, and more particularly IBA‐1þEdUþ cells, were much less
frequently observed in light‐challenged clodronate‐liposome‐
treated Cx3cr1/ mice (Fig 5K). Quantiﬁcation of IBA‐1þ and
IBA‐1þEdUþ cells shows that37% of IBA‐1þ subretinal MPs in
the control liposome‐treated group were IBA‐1þEdUþ and that
circulating monocyte depletion (clodronate liposomes) signiﬁ-
cantly inhibited subretinal IBA‐1þMP accumulation by 60%
(Fig 5L). More importantly, it inhibited IBA‐1þEdUþ accumula-
tion by 85% (Fig 5L). IBA‐1 EdU double labelled retinal
and RPE‐ﬂatmounts of light‐challenged Cx3cr1/ mice
injected intravitreally at day two with EdU marked dividing
corneal epithelial cells (internal positive control) did not reveal
IBA‐1þEdUþMPs (Supporting Information data), which suggests
that local MP proliferation does not play amajor role in subretinal
MP accumulation in light‐challenged Cx3cr1/ mice. Taken
together, the signiﬁcant amount of subretinal IBA‐1þEdUþ
positivity in subretinal MPs in control‐liposome treated mice,
in conjunction with their strong decrease in monocyte depleted
animals and the absence of IBA‐1þEdUþ positive cells after local
EdU administration all suggest that a signiﬁcant proportion of
subretinal MPs are derived from inﬁltrating monocytes.
Subretinal IBA‐1þ EdUMPs likely represent MCs and resident
Mws that were present before EdU administration and migrated
to the subretinal space after the light‐challenge.
To evaluate the inﬂuence of inﬁltrating monocytes on
photoreceptor apoptosis in light‐challenged Cx3cr1/ mice
we prepared TUNEL stained retinal ﬂatmounts at day 14 of
Cx3cr1/mice that had received daily intravenous injections for
4 days during light exposure of either empty control liposomes
(Fig 5M) or clodronate containing liposomes (Fig 5N). Flat-
mounts from control liposome treated Cx3cr1/mice displayed
TUNEL positive cells to a much greater extent than clodronate
liposome‐treated mice. Quantiﬁcation of IBA‐1þ subretinal MPs
at day 14 conﬁrmed that circulating monocyte depletion
signiﬁcantly inhibited subretinal MP accumulation in light‐
challenged Cx3cr1/mice, as observed at day four (Fig 5O) and
nearly completely prevented photoreceptor apoptosis evaluated
on TUNEL stained retinal ﬂatmounts in this model (Fig 5P).
Taken together, our experiments show that subretinal MPs
observed in Cx3cr1/ mice constitute a signiﬁcant degree of
monocyte‐derived MPs recruited from the bloodstream and
seem to have an important role in the induction of photoreceptor
cell death.
Photoreceptor toxicity of wildtype and Cx3cr1/ monocytes
and microglial cells on retinal explants
MCs are recognized to have neuroprotective functions (Trem-
blay et al, 2011), while the sustained presence of iMos can be
detrimental in neurodegenerative conditions such as multiple
sclerosis and stroke (Conductier et al, 2010; Ransohoff, 2009). It
is not clear to what extent activated MCs will become neurotoxic
in pathological conditions. In our experiments the inhibition of
monocyte recruitment to the subretinal space in Cx3cr1/mice
(Ccl2, Ccr2 deletion and monocyte depletion, Figs 3 and 5)
resulted in a 50% reduction of subretinal MP accumulation,
but in a much stronger reduction of photoreceptor cell
death (Figs 4 and 5). These results might suggest that the
photoreceptor degeneration observed in Cx3cr1/ mice is
mainly due to the toxicity of the inﬁltrating monocytes, and
only to a minor extent to the accumulation of resident Mw
and MCs that still accumulate to some extent in Ccl2/Ccr2
deﬁcient and monocyte‐depleted Cx3cr1/ mice. To analyse
the respective toxicity of wildtype and Cx3cr1/ Mos and
MCs on retinal explants, 100,000 C57BL/6 and Cx3cr1/ Mos
(prepared from bone marrow) and MCs (prepared from brain)
adhering to polycarbonate ﬁlters ﬂoating on DMEM were co‐
cultured with C57BL/6 retinal explants for 18 hours (with
the photoreceptors facing the adherent MPs). Photoreceptor
apoptosis was analysed by TUNEL staining of the retinal
explants. TUNELþ nuclei in the photoreceptor cell layer of retinal
explants cultured without Mos (Fig 6A), with C57BL/6 Mos
(Fig 6B), and with Cx3cr1/Mos (Fig 6C) were more numerous
in the presence of Mos and particularly in Cx3cr1/ Mos.
Quantiﬁcation of TUNELþ nuclei/mm2 on 8 explants per group
revealed a signiﬁcant increase in TUNELþ photoreceptors
in C57BL/6 Mos and a further signiﬁcant increase in Cx3cr1/
 Mos compared to retinal explants cultured without MPs.
Interestingly, C57BL/6 and Cx3cr1/ MCs induced little
supplementary photoreceptor apoptosis compared to retinal
explants cultured without MPs and the number of apoptotic
photoreceptors was signiﬁcantly inferior in retinal explants co‐
culturedwith Cx3cr1/MCs compared to Cx3cr1/Mos. These
results suggest that Mos and particularly Cx3cr1/ Mos display
photoreceptor toxicity compared to MCs and might explain
the marked neuroprotective effect of monocyte depletion in
light‐challenged Cx3cr1/ mice.
Blocking CCR2/CCL2 axis protects Cx3cr1/ mice from MP
accumulation and photoreceptor degeneration
We have shown that elevated CCL2 levels and CCR2þ monocyte
inﬁltration are associated with GA (Fig 1). To evaluate whether
the pharmacological inhibition of CCR2 is able to inhibit CX3CR1‐
dependent subretinal MP accumulation and photoreceptor
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degeneration, we treated light‐challenged Cx3cr1/ mice
systemically with a CCR2 inhibitor (RS 102895, Tocris). Control
treated light‐challenged Cx3cr1/ mice revealed numerous
subretinal IBA‐1þ MPs at day 14 (Fig 7A) compared to CCR2
inhibitor treated Cx3cr1/ mice (Fig 7B). Quantiﬁcation of
subretinal MP accumulation shows that systemic pharmacologi-
cal inhibition of CCR2 prevented the accumulation (Fig 7C),
similar to genetic deletion of Ccl2. Furthermore, the occurrence
of photoreceptor apoptosis in control treated light‐challenged
Cx3cr1/ mice (Fig 7D) was signiﬁcantly inhibited in the mice
treated with the CCR2 inhibitor (Fig 7E and quantiﬁcation in 7F).
These results pharmacologically conﬁrm that the inhibition of
the CCL2/CCR2 axis attenuates the photoreceptor degeneration
observed in Cx3cr1/ mice.
Figure 6. Photoreceptor toxicity of wildtype and Cx3cr1/ monocytes and microglial cells on retinal explants.
A–C. Confocal microscopy of flatmounts with z-stack projections (Hoechst in blue) of TUNEL (red) stained retinal-flatmounts of cultured for 18 h without MPs (A),
in contact with C57BL/6 monocytes (B) and Cx3cr1/ monocytes (C).
D. Quantification of TUNELþnuclei/mm2 in the ONL of the different groups (n¼8 per group, one-way Anova Bonferroni significant difference between
explants without MPs and C57BL/6 monocytes p<0.01; y significant difference between explants with C57BL/6 monocytes and Cx3cr1/ monocytes
p<0.01; $ significant difference between Cx3cr1/ monocytes and Cx3cr1/MC p<0.001). All values are represented as mean SEM. Mo: monocytes;
MC: microglial cells. Scale bar¼50mm.
Figure 7. Blocking CCR2/CCL2 axis protects Cx3cr1/ mice from MP accumulation and photoreceptor degeneration.
A, B. IBA-1 stained RPE-flatmounts of PBS (A) and CCR2 inhibitor RS 102895 (B) treated light-challenged Cx3cr1/ mice at d14.
C–E. C) Quantification of IBA-1 positive subretinal MPs/mm2 (n¼6–10 per group, Mann–Whitney p¼0.01). TUNEL stained retinal-flatmounts of PBS (D) and
CCR2 inhibitor (E) treated light-challenged Cx3cr1/ mice at d14.
F. Quantification of TUNEL positive photoreceptor nuclei per retina (n¼4 per group, Mann–Whitney p¼0.028). All values are represented as mean SEM.
Scale bar¼100mm.
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DISCUSSION
Our results show that intraocular CCL2 levels are increased
in GA and that an increase of CCL2 is found in the atrophic
lesions. Elevated Ccl2 mRNA and protein levels in atrophic and
wet AMD (Jonas et al, 2010; Newman et al, 2012) support the
possible involvement of CCL2 in the associated inﬂammation
of both the atrophic and neovascular forms of AMD.
Immunohistochemistry using the pan‐MP marker IBA‐1 on
human controls and early GA donor sections conﬁrmed previous
reports that the photoreceptor cell layer is exempt of MPs in
healthy subjects, but that MPs accumulate in the photoreceptor
cell layer and subretinal space in GA (Combadiere et al, 2007;
Gupta et al, 2003). The density of inner retinal MPs was similar
in GA lesions and macular sections from healthy donors. To
better deﬁne the nature of MPs in GA we performed CCR2
immunohistochemistry to distinguish iMos from resident Mws
and MCs. The CCR2 speciﬁc antibody we used selectively
recognized monocytes in a human blood smear and intraluminal
cells of monocytic morphology in human parafﬁn donor eye
sections (Fig 1). Other than intraluminal cells, none of the
healthy control sections revealed CCR2þ cells in the retina. In
contrast, all the studied GA lesions reproducibly contained
CCR2þ cells in a similar density and CCR2þ cells were observed
in laminar deposits and soft drusen of sections of patients with
early AMD. All the observed CCR2þ cells were also positive for
CD18þ and displayed morphological features of Mos/Mws in
terms of nuclear shape and cytoplasm/nuclear ratio rather than
natural killer T lymphocytes, most likely identifying them as
CCR2þ inﬂammatory monocytes derived MPs. In summary, we
provide the ﬁrst evidence that CCR2þ inﬂammatory monocytes
inﬁltrate the subretinal space in the early atrophic lesions of GA.
Sustained presence of CCR2þ monocyte‐derived inﬂammato-
ry MPs have been shown to play an important role in
neurodegenerative diseases such as models of multiple sclerosis,
experimental autoimmune encephalitis and stroke (Conductier
et al, 2010; Ransohoff, 2009). Recent evidence shows that CCR2þ
monocyte recruitment also plays an important role in photore-
ceptor degeneration in models of retinitis pigmentosa (Guo
et al, 2012), photo‐oxidative stress (Rutar et al, 2012; Suzuki
et al, 2012), and in the carboxyethylpyrrole‐immunization
induced model of AMD (Cruz‐Guilloty et al, 2013). In GA, the
prolonged presence of CCR2þ monocytes could participate in
photoreceptor degeneration, maintain subretinal inﬂammation,
and promote the expansion of the lesion. Previous reports of
subretinal MP accumulation in AMD (Combadiere et al, 2007;
Gupta et al, 2003) using nonspeciﬁc markers could not
distinguish between potentially neurotoxic CCR2þ monocyte‐
derived inﬂammatory MPs (Ransohoff, 2009) and resident MCs.
Cx3cr1 polymorphisms have been associated with wet AMD
in some studies (Anastasopoulos et al, 2012, 2012 #1778;
Combadiere et al, 2007; Tuo et al, 2004; Yang et al, 2010), but
their possible involvement in GA is unknown. Unlike CCL2,
CX3CL1 is constitutively expressed as a transmembrane protein
in retinal neurons (Silverman et al, 2003) and is known to
provide a tonic inhibitory signal to CX3CR1 bearing MCs that
keeps these cells in a quiescent surveillance mode in the brain
(Ransohoff, 2009). CX3CL1 levels in the aqueous humour of
controls were very low; very little cleaved CX3CL1 seems to
reach the aqueous humour under physiological conditions and
no difference was observed in the GA group. However, the
loss of CX3CL1/CX3CR1 signalling in the retina, leads to a strong
age‐dependent increase of subretinal MP accumulation, as
observed in Cx3cr1‐deﬁcient mice compared to wildtype mice.
Importantly, the accumulation of subretinal Cx3cr1‐deﬁcient
MPs is associated with photoreceptor degeneration (Combadiere
et al, 2007; Ma et al, 2009; Raoul et al, 2008a). Although aged
Cx3cr1‐deﬁcient mice do not mimic all aspects of AMD (drusen
formation and RPE atrophy) they do model chronic subretinal
MP accumulation and associated photoreceptor degeneration,
which are hallmarks of AMD (Combadiere et al, 2007; Gupta
et al, 2003). Compared to other models in which subretinal
inﬂammation occurs secondarily to light‐injury or genetic
defects (Cruz‐Guilloty et al, 2013; Guo et al, 2012; Kohno
et al, 2013; Rutar et al, 2012; Suzuki et al, 2012), the Cx3cr1
knockout mouse model presents a primary MP accumulation in
the absence of an inherited retinal degeneration (C57BL/6J
background) (Combadiere et al, 2007). The absence of
confounding factors that lead to photoreceptor cell death in
the Cx3cr1 knockout mouse model makes it a particularly
suitable model for the study of subretinal inﬂammation and its
inﬂuence on photoreceptor homeostasis. Exaggerated subretinal
MP accumulation and photoreceptor degeneration can also be
induced acutely by a light‐challenge in Cx3cr1 knockout mice
(Raoul et al, 2008a). The intensity of the light‐challenge model
used herein was developed to induce subretinal inﬂammation
and subsequent photoreceptor degeneration in the Cx3cr1/
mice but not in Cx3cr1þ/þ mice (see below). The light intensity
we used in these experiments is not strong enough to directly
induce photoreceptor apoptosis in pigmented wildtype animals,
contrary to classically used light‐injury models.
Similar to the human disease, we show that retinal CCL2
production is increased in aged and light‐challenged Cx3cr1
deﬁcient mice (Fig 2). Several lines of evidence suggest that
subretinal Cx3cr1 deﬁcient MPs are the main source of CCL2
release in the subretinal inﬂammation observed in Cx3cr1
knockout mice: CCL2 localized to subretinal Cx3cr1 deﬁcient
MPs in immunohistochemistry, Ccl2 induction observed
in light‐challenged Cx3cr1GFP/GFP mice is suppressed in
Cx3cr1GFP/GFPCcr2RFP/RFP mice (that are protected against
subretinal MP accumulation), Ccl2 mRNA is strongly enriched
in cell‐sorted inﬂammatory monocytes in the eyes of light‐
challenged Cx3cr1GFP/GFPmice and Ccl2 induction is increased in
Cx3cr1/ monocyte‐derived Mf in vitro differentiated in the
presence of POS. Activated Mfs have been described releasing
CCL2 in neuro‐inﬂammatory conditions such as multiple
sclerosis in vivo (Simpson et al, 1998). CX3CR1 is strongly
and constitutively expressed by MCs and upregulated in
monocyte‐derived Mws (Gautier et al, 2012; Geissmann
et al, 2010). CX3CR1/CX3CL1 signalling physiologically
represses the expression of inﬂammatory mediators in CNS
pathology and protects neurons in inﬂammatory conditions
(Cardona et al, 2006; Ransohoff, 2009). We show that the
absence of CX3CR1/CX3CL1 signalling in the subretinal
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environment fails to repress CCL2 induction and that CCL2 is
overexpressed in subretinal inﬂammation in Cx3cr1 deﬁcient
mice (aged and light‐challenged) and in monocyte‐derived
macrophages in the presence of POS in vitro. The accumulation
of CCL2 overexpressing Cx3cr1/ Mos might thereby lead to
a positive feedback in aged‐ and light‐challenged Cx3cr1/
mice, after an initial recruitment through other chemotactic
agents.
Others and we have shown that Cx3cr1 deﬁciency leads to
accumulation of MPs in the central nervous system in
pathological conditions (Cardona et al, 2006; Chinnery
et al, 2011; Combadiere et al, 2007; Kezic et al, 2013). It is
unclear to what extent the recruitment of retinal MCs or blood
born CCR2þ monocytes participates in subretinal MP accumu-
lation. Our experiments of Cx3cr1 and Ccr2 mRNA analysis on
monocytes and puriﬁed retinal MCs, and GFP and RFP
localization in Cx3cr1þ/GFPCcr2þ/RFP conﬁrm that CX3CR1, but
not CCR2, is strongly expressed in retinal MCs (Mizutani
et al, 2011) (Fig 5). As previously described in the brain, the
expression of CCR2 can thereby differentiate freshly recruited
blood monocyte‐derived macrophages in the subretinal space
(Saederup et al, 2010). Submitting Cx3cr1GFP/GFPCcr2þ/RFP mice
to the light‐induced subretinal accumulation of MPs, we show
that CCR2 expressing RFPþ cells participate in subretinal
inﬂammation (Fig 5). These results suggest that CCR2þ
monocytes are recruited to the subretinal space from the blood
in light‐challenged Cx3cr1GFP/GFP mice. Ccr2 mRNA has been
shown to be downregulated in monocyte to macrophage
differentiation (Wong et al, 1997) and we demonstrate its
downregulation in wildtype and Cx3cr1/ monocyte differenti-
ated macrophages in contact with POS after 18 hours. To better
evaluate the extent of CCR2þ Mos in subretinal MP accumula-
tion, we permanently marked the circulating monocytes with
repeated EdU injections prior to and during light‐induced
subretinal recruitment in Cx3cr1/ mice and compared the
numbers of subretinal EdUþ MPs in mice with and without
clodronate‐liposome‐induced circulating monocyte depletion.
Local EdU administration failed to mark subretinal MPs,
suggesting that ocular MP proliferation does not play a
signiﬁcant role in the light‐induced accumulation. The fact that
37% of subretinal MPs were EdU positive in mice receiving
systemic EdU injections and control liposomes, seems to suggest
that at least one third of subretinal MPs originated from the
circulation (Fig 5). Considering that the EdU injections only
marked 76% of circulating monocytes, the extent of Mo
participation in light‐induced subretinal MP accumulation using
this method is possibly underestimated. Indeed, monocyte
depletion inhibited the subretinal IBA‐1þ MP accumulation by
50–60% (Fig 5), suggesting that as many as half of the subretinal
MP population might originate from blood‐borne Mos and half
from local resident Mws or MCs. Similarly, genetic Ccl2 or Ccr2
deletion and CCR2 inhibitors diminished subretinal MP
accumulation by 50–60% in Cx3cr1/and Cx3cr1GFP/GFP mice
with age‐ and in the light‐challenge‐induced model (Figs 2, 3
and 7). Interestingly, although light‐induced subretinal MP
accumulation represents an acute inﬂammation and might
therefore be quite different from the chronic inﬂammation
observed with age, the inhibition of CCL2/CCR2 prevented
subretinal inﬂammation in the same order of magnitude.
Interestingly, the inhibition of CCR2þ monocyte recruitment
(Ccl2 or Ccr2 deletion, monocyte depletion and pharmacological
inhibition Figs 3, 4, 5 and 7) nearly completely inhibited
photoreceptor degeneration in Cx3cr1/ mice. These results
could suggest that (i) the CCR2þ monocyte‐derived MPs
are the main mediators of neurotoxicity and (ii) that the
subretinal accumulation of MPs is in part due to CCR2neg cells,
possibly retinal MCs that display no or little toxicity. Indeed,
our in vitro experiments comparing wildtype and Cx3cr1/ Mo
and MC toxicity on photoreceptors of retinal explants in a co‐
culture system conﬁrm increased toxicity of Mos compared
to MCs and of Cx3cr1/ MPs compared to wildtype MPs
(Fig 6). The neuroprotective effect of inhibiting monocyte
recruitment (via CCL2/CCR2 deletion or circulating monocyte
depletion) in models of photoreceptor degeneration such as
photo‐oxidative stress (Rutar et al, 2012; Suzuki et al, 2012),
the Abca4/Rdh8/ mouse Stargardt/AMD model (Kohno
et al, 2013), and in a carboxyethylpyrrole immunization induced
AMD model (Cruz‐Guilloty et al, 2013), seem to conﬁrm this
observation, while the role of monocyte recruitemnt in rd1
mice remains a point of controversy (Guo et al, 2012; Sasahara
et al, 2008).
Aged Ccl2/ and Ccr2/ mice have also been described to
develop the more discrete subretinal MP accumulation that
occurs in older mice compared to Cx3cr1 deﬁcient mice,
associated with little to no photoreceptor degeneration (see
Supporting Information data) (Chen et al, 2011; Luhmann
et al, 2009). It is not clear how Ccl2 and Ccr2 deﬁciency lead to
subretinal MP accumulation, but subretinal IBA‐1þcells in aged
Ccl2/ and Ccr2/ mice are likely not derived from CCR2þ
monocytes but may at least in part be CCR2‐CX3CR1high MCs
and/or the non‐inﬂammatory CX3CR1þmonocytes, which could
explain the absence of photoreceptor degeneration.
In summary, contrary to CCR2 and CCL2, CX3CR1 and
CX3CL1 are constitutively expressed in the retina similar to the
brain (Ransohoff & Cardona, 2010). CX3CR1 signalling sup-
presses the expression of inﬂammatory mediators, such as CCL2
in CCR2þmonocyte derived inﬂammatory MPs in the subretinal
microenvironment. Contrary to wildtype mice, age‐ and light‐
induced stress in Cx3cr1 deﬁcient animals are sufﬁcient to
induce CCL2 expression and CCR2þmonocyte recruitment to the
subretinal space at a rate exceeding that of their clearance, and
subretinal MPs accumulate. In the brain, Cx3cr1/ Mws clear
less efﬁciently from the injection site compared to wildtype
macrophages (Cardona et al, 2006). We reported that Cx3cr1/
Mws present a similar impaired clearance from the subretinal
space compared to wildtype Mws (Levy et al, 2011) and are
currently investigating the molecular mechanism behind this
phenomenon. The combination of increasedMo recruitment and
decreased MP clearance possibly explains the pathological MP
accumulation observed in Cx3cr1/ mice. This pathological
accumulation, in combination with the increased neurotoxicity
of Cx3cr1/ MPs (Cardona et al, 2006) and in particular
Cx3cr1/Mos (Fig 6) might explain the subretinal inﬂammation
and photoreceptor degeneration observed in Cx3cr1/ mice.
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Chronic CCR2þ inﬂammatory monocyte recruitment has
recently been shown to mediate photoreceptor degeneration in
other models of retinal degeneration and AMD (Cruz‐Guilloty
et al, 2013; Guo et al, 2012; Kohno et al, 2013; Rutar et al, 2012;
Suzuki et al, 2012). Even though Cx3cr1/ mice and other
animal models of photoreceptor degeneration only incompletely
model GA, the observation that, in most models, CCR2þ
inﬂammatory monocytes are toxic to photoreceptors might
have important implications for AMD. Atrophic AMD is
associated with elevated CCL2 levels and CCR2þ inﬂammatory
monocyte inﬁltration into the lesion. The initial lesion formation
might be due to local factors and be independent of
inﬂammatory monocyte inﬁltration, but their presence might
subsequently be a driving factor in the lesion expansion that
leads to central vision loss. Initial lesions often develop
parafoveally (Sarks et al, 1988) and inhibiting their expansion
could be a precious tool in preserving central vision. There are
currently no efﬁcient therapies to inhibit lesion growth and the
central vision destruction in GA. We propose that the continued
recruitment of CCR2þ inﬂammatory monocytes and the release
of neurotoxic factors contribute to the degeneration of the
adjacent retina in atrophic AMD. CCL2/CCR2 blocking agents
hold the potential to inhibit devastating chronic inﬂammation
under the retina in wet and atrophic AMD.
MATERIALS AND METHODS
Animals
Cx3cr1//Ccl2/ mouse strains on C57BL/6 background were
generated from Cx3cr1/ mice (Combadiere et al, 2003) and
Ccl2/ mice (from B. Rollins, Department of Medical Oncology,
Dana‐Farber Cancer Institute, Boston, MA, USA). Cx3cr1GFP/GFPCcr2RFP/
RFPmice were generated as previously described (Saederup et al, 2010).
All mice used in this study were negative for the rd8 mutation. Mice
were maintained at the animal facility under pathogen‐free conditions.
All animals were housed in a 12/12 h light/dark (100–500 lx) cycle
with food and water available ad libitum. Animal experiments were
approved by the Institutional Animal Care and Use Committee of
the Faculté de Médecine Pitié‐Salpétrière.
CCL2 and CCR2 immunohistochemistry
Donor eyes with a known history of AMD and controls were collected
through the Minnesota Lions Eye bank (5 control maculae from 5
patients; 4 early AMD donor maculae from 3 individuals; 10 GA donor
maculae from 7 patients). Postmortem fundus photographs were taken
and the posterior segment was ﬁxed 4 h in 4%PFA, dissected, imbedded
in parafﬁn, and sectioned. Control blood smear was ﬁxed 4 h in 4%PFA
and treated as the parafﬁn sections after rehydration. CCL2 (clone
5d3f7, mouse‐anti‐human, formic acid antigen retrieval, Alexis
Biochemicals), CCR2 (AB32144, rabbit‐anti‐human, citrate buffer
heat antigen retrieval, Abcam), IBA‐1 (rabbit‐anti‐human, formic
acid antigen retrieval, Wako Chemicals), and CD18 (MCA503, rat‐
anti‐human, citrate buffer heat antigen retrieval, Abd Serotec)
immunohistochemistal analyses were performed and revealed using
appropriate ﬂuorescent or horseradish peroxidase coupled secondary
antibodies (Molecular Probe) using a peroxidase substrate kit (Vector).
Blood monocyte and microglial cell preparation
Retinas were collected from PBS perfused 11‐week‐old mice. Tissues
were dissociated by papain in HBSS for 30min at 37°C under agitation
(Neural Tissue Dissociation kit, Miltenyi Biotech). Myeloid cells were
isolated using Percoll gradient (Percoll Plus, GE Healthcare). Cell
suspension was blocked 15min on ice in PBS EDTA 2mM 3% rat serum
with anti‐CD16/CD32 (SeroBlock, Abd Serotec). Resident MCs were
puriﬁed by ﬂow cytometry on ﬂuorescence activated cell sorter
(BDFACSVantage SE, BD Biosciences) as CD11bhigh (PE) and CD45low
(PE‐Cy7) (Abd Serotec) and were recovered directly in lysis buffer.
Enriched monocytes were obtained by centrifugation of whole blood
on a Ficoll Paque layer (GE Healthcare). Positive selection by adhesion
properties on culture dishes was performed 90min to obtain
monocytes. Total mRNA was extracted with Nucleospin RNA XS kit
(Macherey Nagel).
Monocyte culture and photoreceptor outer segment (POS)
incubation
POSwere prepared from porcine retina as previously described (Molday
et al, 1987). C57BL/6 or Cx3cr1/ monocytes were sorted with
EasySep Mouse Monocyte Enrichment kit (StemCells Technology),
seeded in 96 well plates (500,000well1) and POS (2106) were
added in 50ml of DMEM containing 2.5% sucrose. After 18h total RNA
was isolated from the monocytes.
Monocytes, microglial cells and retinal explant cocultures
C57BL/6 or Cx3cr1/ monocytes from bone marrow were
sorted with EasySep Mouse Monocyte Enrichment kit (StemCells
Technology). C57BL/6 or Cx3cr1/ MCs were prepared from
PBS perfused mice. After dissociation of the brain with the
Neural Tissue Dissociation Kit and Percoll gradient centrifugation,
cells were labelled with anti‐CD11b microbeads antibody
(Miltenyi Biotech). MCs were puriﬁed by selection on MS columns
in a magnetic ﬁeld (OctoMACS magnet, Miltenyi). Monocytes
and MCs were then seeded on polycarbonate ﬁlters ﬂoating
on DMEM. C57BL/6 retina were prepared and placed with the
photoreceptors facing 100,000 adherent monocytes or MCs
while control monocytes and MCs were cultivated without the
overlying explant. After 18 h, the explants were carefully removed
and TUNEL labelling was performed on the retinal explants as
described for retina below.
ELISA
Human CCL2 and CX3CL1 concentrations were measured in aqueous
humours sampled during cataract surgery from 18 patients suffering
from geographic AMD and 22 age‐matched control donors. All patients
were treated at the same institution. An inclusion criterion in the study
group was the absence of any retinal or optic nerve disease except GA.
The Medical Ethics Committee of the Hôtel Dieu Hospital approved
the study protocol. Samples were normalized for protein content and
CCL2 was quantiﬁed with Quantikine ELISA assay as described by
the manufacturer (R&D Systems). Optical Density was determined at
450nm.
For mice, retina/RPE/choroid complex was resuspended in 200ml
PBS with protease inhibitor cocktail (Calbiochem), homogenized and
centrifuged at 14,000g for 10min at 4°C and protein concentration
measured using Bradford prior to ELISA.
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Reverse transcription and real‐time polymerase chain reaction
(RT‐PCR)
Total RNA was isolated with Nucleospin RNAII (Macherey Nagel).
Single‐stranded cDNAwas synthesized from total RNA (pretreated with
DNaseI ampliﬁcation grade) using oligo‐dTas primer and superscript II
reverse transcriptase (Life technologies). Subsequent RT‐PCR was
performed using cDNA, Taqman Gene Expression Master Mix (Life
technologies) and primers (0.5 pmol/ml) available upon request. Results
were normalized by expression of b‐actin or S26. PCR reactions were
performed in 45 cycles of 15 s at 95°C, 45 s at 60°C.
Light‐challenge model
Two‐ to four‐month‐old mice were adapted to darkness for 6 h
and pupils were fully dilated with 1% Atropin (Novartis). Animals
were then exposed to green LED light (4500 Lux, JP Vezon
équipements) for 4 days and subsequently kept in cyclic 12 h/12h
normal animal facility conditions. MP accumulation and retinal
degeneration were assessed respectively at 10 and 17 days after
light exposure. For some experiments, mice were treated daily during
green‐light exposition with daily intravenous injections of the CCR2
inhibitor RS 102895 (45mg/mouse, Tocris, Biosciences), 200ml
clodronate‐liposomes or liposomes (provided by Dr. N. Van Rooijen)
in PBS.
In vivo EdU experiments
Mice were treated daily by three intraperitoneal injections of EdU
(25mg/kg, Life Technologies) and once daily with intravenous empty
liposomes (control) or chlodronate liposomes (30mg/kg, FormuMax).
Blood smears were performed and eyes were collected. Choroid/RPE
and retinal ﬂatmounts were labelled with IBA‐1 and revealed for EdU
incorporation (Click‐iT EdU imaging kit, Life Technologies Corporation)
for the quantiﬁcation of subretinal IBA‐1þ and EdUþ cells. Blood
smears, were labelled with anti‐MCSF‐R antibody (Biolegend) and EdU
to calculate the proportion of EdUþ monocytes in the circulation.
Cell sorting
Cx3cr1GFP/GFP mice were exposed to green light for 4 days. Mice were
perfused with cold PBS. Eyes were dissected and tissues were
dissociated by Neural Tissue Dissociation Kit 30min and ﬁltered in
HBSS 10% bovine serum with a 70mm sieve. Cell suspensions were
blocked with PBS EDTA 2mM, 3% rat serum, 2% anti‐CD16/CD32
15min on ice. The tissues were labelled 25min on ice with anti‐
CD11b‐PerCPCy5.5, Ly6C‐PE and Ly6G‐APC (BD Biosciences). 10%
of the whole cell suspension was directly lysed. The cells were sorted
using a MoFlo Astrios (Beckman Coulter) and cells were directly sorted
in lysis buffer to obtain mRNA from CD11bpos Ly6Gneg Ly6Cneg GFPhigh
resident cells, and CD11bpos Ly6Gneg Ly6Cpos GFPlow inﬂammatory
Mo/Mws.
Choroidal ﬂatmounts and MP quantiﬁcation
Eyes were enucleated, ﬁxed in 4% PFA and sectioned at the limbus; the
cornea and lens were discarded. The retinas were carefully peeled from
the RPE/choroid/sclera. Retinas were ﬁxed for additional 20min in cold
acetone. Retinas and choroids were incubated with anti‐IBA‐1 (Wako
Chemicals) followed by secondary antibody anti‐rabbit Alexa 488
(Molecular probes). Choroids and retinas were ﬂatmounted and viewed
with a ﬂuorescence microscope DM5500B (Leica). MPs were counted
on whole RPE/choroidal ﬂatmounts and on the outer segment side of
the retina.
Histology
Eyes were ﬁxed in 0.5% glutaraldehyde, 4% PFA for 2 h, dehydrated
and mounted in Historesin (Leica). 5mm oriented sections crossing
inferior pole, optic nerve and superior pole were cut and stained with
The paper explained
PROBLEM:
Age-related macular degeneration (AMD) is the leading cause
of irreversible blindness in the industrialized world. There
are two clinical forms of late AMD: the fast developing
exudative form defined by choroidal neovascularization (CNV)
and the slow-developing atrophic form characterized by an
extending lesion of the photoreceptors known as geographic
atrophy. While considerable progress has been made in the
treatment of wet AMD, there is currently no efficient treatment
to halt the slow expansion of geographic atrophy and its
pathophysiology is unknown. Inflammatory monocytes
strongly express the chemokine receptor CCR2 and are
attracted to sites of inflammation that express CCL2. In the
central nervous system, excessive monocyte recruitment can
lead to collateral damage and participate in neurodegeneration.
The role of inflammatory monocytes in geographic atrophy is
unknown.
RESULTS:
This is the first study to show that CCL2 levels are elevated in
eyes of patients with geographic atrophy and that CCR2þ
inflammatory monocytes are recruited to the atrophic lesion.
CCL2 levels and CCR2þ monocytes were also higher in eyes of
Cx3cr1 knockout mice that develop subretinal inflammation and
photoreceptor degeneration. Ccl2 and Ccr2 deletion, pharma-
cological CCR2 inhibition and monocyte depletion greatly
diminished subretinal inflammation and photoreceptor degen-
eration in Cx3cr1 knockout mice.
IMPACT:
We propose that the continued recruitment of CCR2þ inflam-
matory monocytes and their release of neurotoxic factors
contribute to the retinal degeneration and lesion expansion
observed in geographic atrophy. CCL2/CCR2 blocking agents hold
the potential to inhibit devastating chronic inflammation under
the retina in geographic atrophy.
Research Article www.embomolmed.org
CCR2þ monocytes in subretinal inflammation
1790  2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. EMBO Mol Med (2013) 5, 1775–1793
toluidin blue. Rows of nuclei in the ONL were counted at different
distances from the optic nerve.
Terminal deoxynucleotidyl transferase dUTP nick end labelling
(TUNEL)
4% PFA ﬁxed retinal ﬂatmounts were pre‐treated with frozen
methanol for 30min and then frozen methanol/acetic acid (2:1) for
another 30min. After washing with PBS, ﬂatmounts were incubated
overnight at 4°C with the reaction mixture as described by
manufacturer’s protocol (In Situ Cell Death Detection Kit, Roche
Diagnostics) and then for 90min at 37°C. After reaction was stopped
by washing with PBS at RT, nuclei were counterstained with Hoechst
(Sigma–Aldrich).
Fundus photography
Mice were anaesthetized by i.p. injection of ketamine (50mg/kg) and
xylazine (10mg/kg). Pupils were fully dilated with 0.5% tropicamide
and 10% neosynephrine. Coverslips positioned on the mouse cornea
were used as a contact glass. Fundus photographs were taken with a
digital CCD camera (Nikon D3) coupled with an endoscope (Karl Storz)
as previously described (Paques et al, 2006).
Statistics
Graph Pad Prism 5 (GraphPad Software) was used for data analysis
and graphic representation. All values are reported as mean SEM.
Statistical analysis was performed by one‐way or two‐way Anova
analysis of variance followed by Bonferroni post‐test, students t‐tes or
Mann–Whitney test for comparison among means depending on the
experimental design. The p‐values are indicated in the ﬁgure legends.
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